These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 27056071)

  • 1. Factors predicting treatment adherence in patients with adult attention-deficit/hyperactivity disorder: a preliminary study.
    Semerci B; Taskıran S; Tufan E; Şanlı I
    Atten Defic Hyperact Disord; 2016 Sep; 8(3):139-47. PubMed ID: 27056071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment compliance or medication adherence in children and adolescents on ADHD medication in clinical practice: results from the COMPLY observational study.
    Wehmeier PM; Dittmann RW; Banaschewski T
    Atten Defic Hyperact Disord; 2015 Jun; 7(2):165-74. PubMed ID: 25416667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Open-Label, Randomized Trial of Methylphenidate and Atomoxetine Treatment in Children with Attention-Deficit/Hyperactivity Disorder.
    Shang CY; Pan YL; Lin HY; Huang LW; Gau SS
    J Child Adolesc Psychopharmacol; 2015 Sep; 25(7):566-73. PubMed ID: 26222447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in Utilization Patterns among Medications in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: a 36-Month Retrospective Study Using the Korean Health Insurance Review and Assessment Claims Database.
    Bhang SY; Hwang JW; Kwak YS; Joung YS; Lee S; Kim B; Sohn SH; Chung US; Yang J; Hong M; Bahn GH; Choi HY; Oh IH; Lee YJ
    J Korean Med Sci; 2016 Aug; 31(8):1284-91. PubMed ID: 27478341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cessation of attention deficit hyperactivity disorder drugs in the young (CADDY)--a pharmacoepidemiological and qualitative study.
    Wong IC; Asherson P; Bilbow A; Clifford S; Coghill D; DeSoysa R; Hollis C; McCarthy S; Murray M; Planner C; Potts L; Sayal K; Taylor E
    Health Technol Assess; 2009 Oct; 13(50):iii-iv, ix-xi, 1-120. PubMed ID: 19883527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploratory analysis of early treatment discontinuation and clinical outcomes of patients with attention-deficit/hyperactivity disorder.
    Wu SH; Wang K; Chen Y; Wang WQ; Wang F; Montgomery W; Treuer T
    Asia Pac Psychiatry; 2017 Mar; 9(1):. PubMed ID: 26663807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Atomoxetine and Osmotic Release Oral System-Methylphenidate on Executive Functions in Patients with Combined Type Attention-Deficit/Hyperactivity Disorder.
    Ince Tasdelen B; Karakaya E; Oztop DB
    J Child Adolesc Psychopharmacol; 2015 Aug; 25(6):494-500. PubMed ID: 26218871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review of medication adherence in children and adults with ADHD.
    Adler LD; Nierenberg AA
    Postgrad Med; 2010 Jan; 122(1):184-91. PubMed ID: 20107302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ADHD medication use, adherence, persistence and cost among Texas Medicaid children.
    Barner JC; Khoza S; Oladapo A
    Curr Med Res Opin; 2011; 27 Suppl 2():13-22. PubMed ID: 21973228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-Term Pharmacotherapy of Adults With Attention Deficit Hyperactivity Disorder: A Literature Review and Clinical Study.
    Fredriksen M; Peleikis DE
    Basic Clin Pharmacol Toxicol; 2016 Jan; 118(1):23-31. PubMed ID: 26404187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Remarkable Reduction of Cocaine Use in Dual Disorder (Adult Attention Deficit Hyperactive Disorder/Cocaine Use Disorder) Patients Treated with Medications for ADHD.
    Manni C; Cipollone G; Pallucchini A; Maremmani AGI; Perugi G; Maremmani I
    Int J Environ Res Public Health; 2019 Oct; 16(20):. PubMed ID: 31618876
    [No Abstract]   [Full Text] [Related]  

  • 12. Attention deficit hyperactivity disorder pharmacotherapy in Slovenian adults: a population-based study.
    Stuhec M; Locatelli I
    Int J Clin Pharm; 2018 Apr; 40(2):341-344. PubMed ID: 29468526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adherence to stimulants in adult ADHD.
    O'Callaghan P
    Atten Defic Hyperact Disord; 2014 Jun; 6(2):111-20. PubMed ID: 24604104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of one-year pharmacological treatment of adult attention-deficit/hyperactivity disorder (ADHD): an open-label prospective study of time in treatment, dose, side-effects and comorbidity.
    Fredriksen M; Dahl AA; Martinsen EW; Klungsøyr O; Haavik J; Peleikis DE
    Eur Neuropsychopharmacol; 2014 Dec; 24(12):1873-84. PubMed ID: 25453480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study.
    Quintana H; Cherlin EA; Duesenberg DA; Bangs ME; Ramsey JL; Feldman PD; Allen AJ; Kelsey DK
    Clin Ther; 2007 Jun; 29(6):1168-77. PubMed ID: 17692731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of pharmacological treatment outcomes with atomoxetine or methylphenidate in patients with attention-deficit/hyperactivity disorder from China, Egypt, Lebanon, Russian Federation, Taiwan, and United Arab Emirates.
    Treuer T; Feng Q; Desaiah D; Altin M; Wu S; El-Shafei A; Serebryakova E; Gado M; Faries D
    Int J Clin Pract; 2014 Sep; 68(9):1152-60. PubMed ID: 24703228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Better efficacy for the osmotic release oral system methylphenidate among poor adherents to immediate-release methylphenidate in the three ADHD subtypes.
    Chou WJ; Chou MC; Tzang RF; Hsu YC; Gau SS; Chen SJ; Wu YY; Huang YF; Liang HY; Cheng H
    Psychiatry Clin Neurosci; 2009 Apr; 63(2):167-75. PubMed ID: 19335386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medication persistence in Turkish children and adolescents with attention-deficit/hyperactivity disorder.
    Ayaz M; Ayaz AB; Soylu N; Yüksel S
    J Child Adolesc Psychopharmacol; 2014 Oct; 24(8):442-7. PubMed ID: 25010598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of negative media publicity on attention-deficit/hyperactivity disorder medication in Taiwan.
    Wang LJ; Lee SY; Yuan SS; Yang CJ; Yang KC; Lee TL; Shyu YC
    Pharmacoepidemiol Drug Saf; 2016 Jan; 25(1):45-53. PubMed ID: 26549311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment persistence in attention deficit/hyperactivity disorder: a retrospective analysis of patients initiated on lisdexamfetamine vs other medications.
    Setyawan J; Guérin A; Hodgkins P; Gauthier G; Cloutier M; Wu E; Erder MH
    J Med Econ; 2013 Nov; 16(11):1275-89. PubMed ID: 24004347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.